N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Stuttering and Neuromodulation

Sponsor: NYU Langone Health • ClinicalTrials.gov ID: NCT07222163

Registry updated: 2026-09-02
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The purpose of this study is to collect preliminary data on the efficacy of transcranial direct current stimulation (tDCS) combined with traditional behavioral techniques to reduce stuttering severity and negative impact in adults who stutter. The study also aims to explore neuroplastic changes (i.e., regional activation and functional connectivity) resulting from combined tDCS + speech therapy.

Interventions

  • Soterix Medical 1x1 tDCS system (Device)
    Stimulation (2.0 mA for 30 minutes) will occur during speech therapy sessions focused on practicing speech techniques. Sham stimulation will mimic the physical sensation without active current.
  • Speech therapy sessions (Behavioral)
    Each of the ten weekly sessions will begin with 15 minutes of strategy practice, providing participants with the opportunity to rehearse light contact and easy onset techniques prior to the tDCS-enhanced speaking task.

Eligibility criteria

Inclusion Criteria: 1. Adults aged 18 to 65 years. 2. Diagnosis of developmental stuttering, verified by a licensed speech-language pathologist. 3. Mild-to-moderate or greater stuttering severity, defined as a score of 20 or higher on the Stuttering Severity Instrument-Fourth Edition (SSI-4). 4. English as a primary language. 5. Right-handedness (to minimize variability in neural lateralization). 6. Willing and able to attend all study sessions and follow study procedures. Exclusion Criteria: 1. Have a history of neurological, psychiatric, or medical conditions that are contraindicated for tDCS. 2. Are currently taking medications known to affect cortical excitability. 3. Have a history of seizures or epilepsy. 4. Are pregnant or planning to become pregnant during the study period. 5. Have metal implants in the head (excluding dental work) or other contraindications to electrical brain stimulation. 6. Any skin disorder or skin sensitive area near stimulation locations.

Conditions

Stuttering

Locations

  • NYU Langone Health — New York, New York, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record